Cleared Traditional

K896721 - MODEL 7-AT TREATMENT CHAMBER

K896721 is an FDA 510(k) clearance for MODEL 7-AT TREATMENT CHAMBER, manufactured by J. H. Emerson Co.. The device is a Class 2 General Hospital device with product code LGM cleared through the Traditional 510(k) pathway after a 55-day FDA review.

K896721 · J. H. Emerson Co. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1990
Decision
55d
Days
Class 2
Risk

K896721 is an FDA 510(k) clearance for the MODEL 7-AT TREATMENT CHAMBER. Classified as Chamber, Patient Isolation (product code LGM), Class II - Special Controls.

Submitted by J. H. Emerson Co. (Cambridge, US). The FDA issued a Cleared decision on January 22, 1990 after a review of 55 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5450 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all J. H. Emerson Co. devices

FDA 510(k) Submission Details - K896721

510(k) Number K896721 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 28, 1989
Decision Date January 22, 1990
Days to Decision 55 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 129d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LGM Device Classification - Class 2, Special Controls

Product Code LGM Chamber, Patient Isolation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LGM Chamber, Patient Isolation

Devices cleared under the same product code (LGM) and FDA review panel - the closest regulatory comparables to K896721.
Carecube Negative Pressure Isolation Chamber
K231256 · Carecubes, Inc. · Jan 2024
MICROBACT 12A SYSTEM, 12B SYSTEM, AND 24E SYSTEM
K912444 · Radiometer America, Inc. · Feb 1992
INFECTIOUS DISEASE PROTECTION KIT, DISPOSABLE
K874306 · Busse Hospital Disposables, Inc. · Mar 1988
ANAGO ISOLATION MASK (#80-950)
K864116 · Anago, Inc. · Nov 1986